Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities

Journal of Clinical Epidemiology

Volumn 58, Issue 8, 2005, Pages 757-762

  Anderson, Geoffrey M ^a,b   Bronskill, Susan E ^a,b   Mustard, Cameron A ^a,c   Culyer, Anthony ^c   Alter, David A ^b,d,e   Manuel, Douglas G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c INSTITUTE FOR WORK AND HEALTH   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Access; Clinical epidemiology; Health disparities; Health outcomes; Population health; Socioeconomic status

Indexed keywords

BIOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DATA BASE; EDUCATION; EMPLOYMENT; EPIDEMIOLOGICAL DATA; ETHICS; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HOMEOSTASIS; HUMAN; INCOME; MEDICAL RESEARCH; MORTALITY; OUTCOMES RESEARCH; POLICY; POPULATION RESEARCH; PRIORITY JOURNAL; PRODUCTIVITY; PUBLIC HEALTH SERVICE; PUBLIC OPINION; REVIEW; RISK FACTOR; RISK REDUCTION; SCIENTIFIC LITERATURE; SELF ESTEEM; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 22044452002     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2004.10.020     Document Type: Article

References (29)

1. J.W. Frank, and J.F. Mustard The determinants of health from a historical perspective Daedalus 123 1994 1 19
2. M.G. Marmot, G.D. Smith, S. Stansfeld, C. Patel, F. North, J. Head, I. White, E. Brunner, and A. Feeney Health inequalities among British civil servants: the Whitehall II study Lancet 337 1991 1387 1393
3. M. Marmot The influence of income on health: views of an epidemiologist. Does money really matter? Or is it a marker for something else? Health Aff (Millwood) 21 2002 31 46
4. A. Deaton Policy implications of the gradient of health and wealth. An economist asks, would redistributing income improve population health? Health Aff (Millwood) 21 2002 13 30
5. A.R. Tarlov Public policy frameworks for improving population health Ann NY Acad Sci 896 1999 281 293
6. R.G. Evans, and G.L. Stoddart Producing health, consuming health care R.G. Evans M.L. Barer T.R. Marmor Why are some people healthy and others not? The determinants of health of populations 1994 Aldine de Gruyter New York 27 64
7. J. Cassel The contribution of the social environment to host resistance: the Fourth Wade Hampton Frost Lecture. 1976 Am J Epidemiol 141 1995 798 814 discussion, 797
8. J.R. Kaplan, M.R. Adams, T.B. Clarkson, S.B. Manuck, C.A. Shively, and J.K. Williams Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models Psychosom Med 58 1996 598 611
9. P.M. Lantz, J.S. House, J.M. Lepkowski, D.R. Williams, R.P. Mero, and J. Chen Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults JAMA 279 1998 1703 1708
10. N.P. Chin, A. Monroe, and K. Fiscella Social determinants of (un)healthy behaviors Educ Health (Abingdon) 13 2000 317 328
11. J.N. Lavis, and G.L. Stoddart Can we have too much health care? Daedalus 123 1994 43 60
12. R.G. Evans Health care as a threat to health: defense, opulence, and the social environment Daedalus 123 1994 21 42
13. R.H. Fletcher, S.W. Fletcher, and E.H. Wagner Clinical epidemiology: the essentials ed 3. 1998 Williams & Wilkins Baltimore, MD
14. G.H. Guyatt, D.L. Sackett, and D.J. Cook Evidence-Based Medicine Working Group. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? JAMA 270 1993 2598 2601
15. T.A. Furukawa, G.H. Guyatt, and L.E. Griffith Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses Int J Epidemiol 31 2002 72 76
16. F.A. McAlister Commentary: Relative treatment effects are consistent across the spectrum of underlying risks... usually Int J Epidemiol 31 2002 76 77
17. Hypertension Detection and Follow-up Program Cooperative Group Educational level and 5-year all-cause mortality in the Hypertension Detection and Follow-up Program Hypertension 9 1987 641 646
18. Scandinavian Simvastatin Survival Study (4S). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
19. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M. Arnold, C.C. Wun, B.R. Davis, and E. Braunwald Cholesterol and Recurrent Events Trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
20. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
21. J.R. Downs, M. Clearfield, S. Weis, E. Whitney, D.R. Shapiro, P.A. Beere, A. Langendorfer, E.A. Stein, W. Kruyer, and A.M. Gotto Jr. Air Force/Texas Coronary Atherosclerosis Prevention Study. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS JAMA 279 1998 1615 1622
22. J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, P.W. MacFarlane, J.H. McKillop, and C.J. Packard West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
23. P. Tugwell, K. Bennett, D. Feeny, G. Guyatt, and R.B. Haynes A framework for the evaluation of technology: the technology assessment iterative loop D. Feeny G. Guyatt P. Tugwell Health care technology: effectiveness, efficiency, and public policy 1986 Institute for Research on Public Policy Montreal 41 56
24. D.A. Alter, C.D. Naylor, P. Austin, and J.V. Tu Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction N Engl J Med 34 1999 1359 1367
25. M.K. Kapral, H. Wang, M. Mamdani, and J. Tu Effect of socioeconomic status on treatment and mortality after stroke Stroke 33 2002 268 273
26. K. Fiscella, P. Franks, M.R. Gold, and C.M. Clancy Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care JAMA 283 2000 2579 2584
27. H.R. Burstin, S.R. Lipsitz, and T.A. Brennan Socioeconomic status and risk for substandard medical care JAMA 268 1992 2383 2387
28. B.J. O'Brien, D. Heyland, S. Richardson, M. Levine, and M.F. Drummond Users' guides to the medical literature. XIII. How to use an article on economic analysis. B. What are the results and will they help me in caring for my patients? JAMA 277 1997 1802 1806 [Erratum in: JAMA 1997;278:1064]
29. J.D. Graham, P.S. Corso, J.M. Morris, M. Segui-Gomez, and M.C. Weinstein Evaluating the cost-effectiveness of clinical and public health measures Annu Rev Public Health 19 1998 125 152